L

Lord Jackson of Peterborough (Con)

Speaking in the House of Lords on 19 November 2026

Debate

Alzheimer’s Disease and Vascular Dementia

Contribution

My Lords, I am delighted to have the opportunity to raise this issue, which touches so many of our lives, including my own family’s. I know it is essentially a cross-party policy matter, and I am certain that the Minister, who I served with in the other place, is committed to the cause and will listen with great care and respond accordingly. I am indebted to Alzheimer’s Research UK and the Alzheimer’s Society for their work and for their help and support for me. The purpose of this debate is to address the present inadequacy in respect of the provision of local community support for patients diagnosed with Alzheimer’s disease and vascular dementia. The NHS has highlighted research showing that there are more than 944,000 people in the UK living with dementia—one in 11 people over the age of 65. It has been estimated that by 2030 the number of people with dementia in the UK will exceed 1 million, and the Alzheimer’s Society projects that by 2040 that figure may well exceed 1.4 million people. Dementia is the leading cause of death in the UK. The need for adequate local community support is acute and growing dramatically. Currently, the NHS recommends that individuals diagnosed with dementia should be given a care plan to be reviewed at least once a year, as both individuals and carers for those with dementia often require care and support. This is provided through the NHS, local authority adult social care services and a combination of national and local charities, as well as family and friends. However, the quality and availability of community support for patients diagnosed with Alzheimer’s disease and vascular dementia is demonstrably insufficient. Research by King’s College London identified issues concerning the accessibility of community support, including limited guidance, not being taken seriously and reports that emergency departments, rather than clinical expertise in the community, frequently become the path of least resistance to accessing care. This is corroborated by the Alzheimer’s Society’s 2025 report, Left in the Dark, which stated that one in five people affected by dementia have received no healthcare and no social care or financial support. Of those who received support, fewer than half were satisfied with it, with only 29% saying dementia-related healthcare was easy to access. A 2025 Care England and Dementia Forward report identified specific challenges for those seeking to access community support with young-onset dementia. It found that 95% of local authorities do not record young-onset dementia as a distinct category, while just 10% of local authorities report having any specialist young-onset dementia support locally. Other issues flagged by the Care Quality Commission’s 2025 report included lengthy waiting times for diagnosis and community support delivery, a lack of staff knowledge from care providers, poor communications and inequalities of care delivery. Regrettably, although some modelling suggests that 70% of care home residents are people living with dementia, there is no legal requirement for adult social care to undertake dementia training, and only 29% of staff in England in 2024 were recorded as having undertaken any dementia training. There are welcome signs, however, that the Government are seeking to engage with this issue. The ongoing Casey commission on adult social care has already outlined initial recommendations, which the Government have accepted in full, including using funding from the Dame Barbara Windsor dementia goals programme to trial new dementia drugs and appointing a new dementia tsar with national responsibility for the prevention, treatment and care of dementia. The Government have also recently committed to additional funding towards further dementia research. None the less, further action is required from the Government that would meaningfully impact the provision of community support for patients and carers affected. Since the 2024 general election, shadow Health Ministers have criticised this Government for the lack of priority given to improving dementia care and outcomes, including the removal of dementia diagnosis targets from NHS guidance to local health systems in 2025. One opportunity to make a difference through legislation was recently missed in the other place in Committee on the Health Bill, currently in our House in Committee. A cross-party amendment tabled by Joe Robertson MP was rejected and not added to the Bill; it would have required the Government to publish an annual report on the provision of dementia care. Alzheimer’s Research UK said that it welcomed the Government’s continuing development of a modern service framework for frailty and dementia, but it must be ambitious if it is to transform outcomes for people living with dementia. It recommends prioritising the following areas, which I hope that the Minister will address in her remarks. First, it suggested adopting innovation faster through a new national innovation implementation programme. My noble friend Lord Cameron’s recent public engagements as president of Alzheimer’s Research UK have focused on the ground-breaking research and innovation in Alzheimer’s drugs, which could have a transformative impact on the treatment of the disease in the near to medium-term future. I know that he is very optimistic about that and will no doubt elucidate that issue in his forthcoming Alzheimer’s podcast. Supporting this progress will facilitate the solutions that make the biggest difference to future generations’ engagement with Alzheimer’s and dementia. Secondly, delivering a consistent post-diagnostic national dementia pathway through standardised pathways for referral, assessment and treatment, with an immediate 18-week referral to diagnosis and care plan target, aims for the standardisation of best practice. Thirdly, we should measure what matters and hold the system to account through robust data mechanisms and reporting. This might, I hope, include a regular patient review with a named professional co-ordinating, guiding and proactively supporting in line with NICE guideline NG97. Additionally, there is a need for earlier access to transport, more equitable and consistent care across the country, increased access to research and innovation, and more proactive, personalised and joined-up care. I will finish with a few questions to the Minister, to which I know others will wish to contribute. How will the Government’s plans for developing Alzheimer’s and dementia community care consider the needs of those with young-onset dementia as a currently underrepresented group of individuals suffering with these diseases? What plans are there to support unpaid carers and to ensure that they have the support they need for training, respite care, home equipment and adaptions, benefits, legal planning, information and access to expertise, as well as very basic issues such as domiciliary care for the patient? Beyond funding, what regulatory pathways are the Government creating to accommodate groundbreaking Alzheimer’s and dementia drug and treatment research and development? Finally, what support is planned for peer and community initiatives such as dementia cafés, activity groups and services such as Singing for the Brain? This Government have an historic opportunity to tackle this difficult and multigenerational health emergency. If they do, they will have widespread support and good will. I thank the Minister in advance for her forbearance and very much look forward to the contributions from other noble Lords.

More from Lord Jackson of Peterborough (Con)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.